Bharat Edition

Bharatstox

← All stocks

Dhanuka Agritech Ltd.

NSE: DHANUKA · Chemicals

Sector

Chemicals

Size band

Small cap

Market cap

4,538cr

P/E

17.1

ROE

22.3%

Dividend yield

0.2%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin12.0%
peer 14.0%
Revenue growth−12.5%
peer 0.6%
Dhanuka Agritech Ltd.peer median

Peer set

Pesticides & Agrochemicals · largest 12 of 17 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
UPL Ltd.13.0%10.5%
PI Industries Ltd.22.0%−10.4%
Sumitomo Chemical India Ltd.22.0%0.6%
BASF India Ltd.10.0%24.5%
Fine Organic Industries Ltd.25.0%18.0%
Sharda Cropchem Ltd.17.0%9.0%
Rallis India Ltd.18.0%6.8%
Dhanuka Agritech Ltd.12.0%−12.5%
NACL Industries Ltd.11.0%−14.5%
Bharat Rasayan Ltd.15.0%−10.3%
Insecticides (India) Ltd.11.0%−11.4%
India Pesticides Ltd.14.0%−8.4%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Dhanuka Agritech Ltd..

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Dhanuka Agritech Ltd..

Shareholding

change across 4 filings
CategoryJun 26Mar 26Dec 25Sep 25Change
Promoters69.869.769.769.7+0.1
Foreign institutions1.61.92.12.3−0.7
Domestic institutions18.719.418.818.1+0.6
Retail & others9.88.99.49.9−0.1

As filed with the exchange for the periods ending Sep 25 to Jun 26.

Filings

latest 25 of 256
  • Resignation of Director/KMP/SMP15 Oct 2026
    Medium impactResignationFiling PDF ↗
  • Resignation15 Oct 2026
    Medium impactResignationFiling PDF ↗
  • Product launch14 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Certificate under SEBI (Depositories and Participants) Regulations, 20186 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Action(s) taken or orders passed6 Oct 2026
    RoutineGeneralFiling PDF ↗
  • Product launch25 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Trading Window25 Sept 2026
    Medium impactInsider TradingFiling PDF ↗
  • Intimation regarding Product Launch22 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Product launch22 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Credit Rating17 Sept 2026
    Medium impactCredit RatingFiling PDF ↗
  • Intimation of Credit Rating17 Sept 2026
    Medium impactCredit RatingFiling PDF ↗
  • General Updates17 Sept 2026
    RoutineGeneralFiling PDF ↗
  • Intimation of receipt of In-principle Approvals for listing of up to 50,000 Equity Shares of face value of Rs. 2 each under Dhanuka Employee Stock Option Plan 2026 ("ESOP 2026"/"Plan" )17 Sept 2026
    RoutineGeneralFiling PDF ↗
  • General Updates28 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Intimation of Incorporation of Wholly Owned Subsidiary in Ireland, Europe28 Aug 2026
    Medium impactInvestmentFiling PDF ↗
  • Demise13 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates7 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting5 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Copy of Newspaper Publication4 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting3 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates3 Aug 2026
    RoutineGeneralFiling PDF ↗
  • General Updates3 Aug 2026
    Medium impactAppointmentFiling PDF ↗
  • Investor Presentation3 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Updates3 Aug 2026
    High impactM&AFiling PDF ↗
  • General Updates3 Aug 2026
    RoutineGeneralFiling PDF ↗

The 25 most recent of 256 filings we hold for DHANUKA, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.